Aggregation of neuronal protein α-synuclein leads to the formation of amyloid fibrils, which are associated with the development of Parkinson's disease. The mechanism of α-synuclein pathology is not fully understood and is a subject of active research in the field. To tackle this problem, the fusions of fluorescent proteins to α-synuclein C-terminus are often used in cellular and animal studies. The effects induced by such α-synuclein sequence extension on α-synuclein aggregation propensity are, however, not systematically examined despite the evidence that the negatively charged C-terminus plays a critical role in the regulation of α-synuclein aggregation. In this work, we investigated how the charge and length variations of the C-terminus affect the aggregation propensity of α-synuclein. To address these questions, we prepared mutants of α-synuclein carrying additional moieties of different charge and length at the protein C-terminus. We determined the rates of two different aggregation stages (primary nucleation and elongation) based on a thioflavin T kinetic assay. We observed that all mutants bearing neutrally charged moieties of different length fibrilized slower than wild-type α-synuclein. The primary nucleation and elongation rates strongly decreased with increase of the C-terminal extension length. Meanwhile, charge variation of the C-terminus significantly changed the rate of α-synuclein nucleation, but did not markedly affect the rate of fibril elongation. Our data demonstrate that both the charge and length of the C-terminus play an important role at the stage of initial fibril formation, but the stage of fibril elongation is affected mainly by the length of C-terminal extension. In addition, our results suggest that there are at least two steps of incorporation of α-synuclein monomers into the amyloid fibril: namely, the initial monomer binding to the fibril end (charge-dependent, relatively fast), and the subsequent conformational change of the protein (charge-independent, relatively slow, and thus the rate-limiting step).

Department of Chemical Physics and Optics Faculty of Mathematics and Physics Charles University Prague Czech Republic

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Fink A.L. The aggregation and fibrillation of α-synuclein. Acc. Chem. Res. 2006;39:628–634. PubMed

Luna E., Luk K.C. Bent out of shape: α-synuclein misfolding and the convergence of pathogenic pathways in Parkinson’s disease. FEBS Lett. 2015;589(24 Pt A):3749–3759. PubMed PMC

Herva M.E., Spillantini M.G. Parkinson’s disease as a member of prion-like disorders. Virus Res. 2015;207:38–46. PubMed

Emanuele M., Chieregatti E. Mechanisms of α-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous role. Biomolecules. 2015;5:865–892. PubMed PMC

Butler B., Sambo D., Khoshbouei H. α-Synuclein modulates dopamine neurotransmission. J. Chem. Neuroanat. 2016;83–84:41–49. PubMed PMC

Breydo L., Wu J.W., Uversky V.N. α-Synuclein misfolding and Parkinson’s disease. Biochim. Biophys. Acta. 2012;1822:261–285. PubMed

Uversky V.N., Eliezer D. Biophysics of Parkinson’s disease: structure and aggregation of α-synuclein. Curr. Protein Pept. Sci. 2009;10:483–499. PubMed PMC

Oueslati A. Implication of α-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade? J. Parkinsons Dis. 2016;6:39–51. PubMed PMC

Oueslati A., Fournier M., Lashuel H.A. Role of post-translational modifications in modulating the structure, function and toxicity of α-synuclein: implications for Parkinson’s disease pathogenesis and therapies. Prog. Brain Res. 2010;183:115–145. PubMed

Tarutani A., Suzuki G., Hasegawa M. The effect of fragmented pathogenic α-synuclein seeds on prion-like propagation. J. Biol. Chem. 2016;291:18675–18688. PubMed PMC

van Raaij M.E., van Gestel J., Subramaniam V. Concentration dependence of α-synuclein fibril length assessed by quantitative atomic force microscopy and statistical-mechanical theory. Biophys. J. 2008;95:4871–4878. PubMed PMC

Vilar M., Chou H.T., Riek R. The fold of α-synuclein fibrils. Proc. Natl. Acad. Sci. USA. 2008;105:8637–8642. PubMed PMC

Der-Sarkissian A., Jao C.C., Langen R. Structural organization of α-synuclein fibrils studied by site-directed spin labeling. J. Biol. Chem. 2003;278:37530–37535. PubMed

Qin Z., Hu D., Fink A.L. Role of different regions of α-synuclein in the assembly of fibrils. Biochemistry. 2007;46:13322–13330. PubMed

Nath S., Meuvis J., Engelborghs Y. Early aggregation steps in α-synuclein as measured by FCS and FRET: evidence for a contagious conformational change. Biophys. J. 2010;98:1302–1311. PubMed PMC

Arosio P., Knowles T.P., Linse S. On the lag phase in amyloid fibril formation. Phys. Chem. Chem. Phys. 2015;17:7606–7618. PubMed PMC

Fändrich M. Absolute correlation between lag time and growth rate in the spontaneous formation of several amyloid-like aggregates and fibrils. J. Mol. Biol. 2007;365:1266–1270. PubMed

Fauerbach J.A., Yushchenko D.A., Jares-Erijman E.A. Supramolecular non-amyloid intermediates in the early stages of α-synuclein aggregation. Biophys. J. 2012;102:1127–1136. PubMed PMC

Schmit J.D., Ghosh K., Dill K. What drives amyloid molecules to assemble into oligomers and fibrils? Biophys. J. 2011;100:450–458. PubMed PMC

Buell A.K., Galvagnion C., Dobson C.M. Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation. Proc. Natl. Acad. Sci. USA. 2014;111:7671–7676. PubMed PMC

Kim H.J., Chatani E., Paik S.R. Seed-dependent accelerated fibrillation of α-synuclein induced by periodic ultrasonication treatment. J. Microbiol. Biotechnol. 2007;17:2027–2032. PubMed

Shvadchak V.V., Claessens M.M., Subramaniam V. Fibril breaking accelerates α-synuclein fibrillization. J. Phys. Chem. B. 2015;119:1912–1918. PubMed

Wördehoff M.M., Bannach O., Birkmann E. Single fibril growth kinetics of α-synuclein. J. Mol. Biol. 2015;427(6 Pt B):1428–1435. PubMed

So M., Yagi H., Goto Y. Ultrasonication-dependent acceleration of amyloid fibril formation. J. Mol. Biol. 2011;412:568–577. PubMed

Hansen C., Björklund T., Li J.Y. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP. Neurobiol. Dis. 2013;56:145–155. PubMed

Bodhicharla R., Nagarajan A., de Pomerai D. Effects of α-synuclein overexpression in transgenic Caenorhabditis elegans strains. CNS Neurol. Disord. Drug Targets. 2012;11:965–975. PubMed PMC

Kakish J., Allen K.J., Lee J.S. Novel dimer compounds that bind α-synuclein can rescue cell growth in a yeast model overexpressing α-synuclein. A possible prevention strategy for Parkinson’s disease. ACS Chem. Neurosci. 2016;7:1671–1680. PubMed

Fernandes J.T., Chutna O., Outeiro T.F. A novel microfluidic cell co-culture platform for the study of the molecular mechanisms of Parkinson’s disease and other synucleinopathies. Front. Neurosci. 2016;10:511. PubMed PMC

Lee I.H., Kim H.Y., Paik S.R. Dequalinium-induced cell death of yeast expressing alpha-synuclein-GFP fusion protein. Neurochem. Res. 2008;33:1393–1400. PubMed

McLean P.J., Kawamata H., Hyman B.T. α-Synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience. 2001;104:901–912. PubMed

Rockenstein E., Schwach G., Masliah E. Lysosomal pathology associated with α-synuclein accumulation in transgenic models using an eGFP fusion protein. J. Neurosci. Res. 2005;80:247–259. PubMed

Keem J.O., Lee I.H., Chung B.H. Splitting and self-assembling of far-red fluorescent protein with an engineered β strand peptide: application for α-synuclein imaging in mammalian cells. Biomaterials. 2011;32:9051–9058. PubMed

van Ham T.J., Esposito A., Bertoncini C.W. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of α-synuclein aggregation. J. Mol. Biol. 2010;395:627–642. PubMed

Prusiner S.B., Woerman A.L., Giles K. Evidence for α-synuclein prions causing multiple system atrophy in humans with Parkinsonism. Proc. Natl. Acad. Sci. USA. 2015;112:E5308–E5317. PubMed PMC

Anderson V.L., Webb W.W. Transmission electron microscopy characterization of fluorescently labelled amyloid β 1–40 and α-synuclein aggregates. BMC Biotechnol. 2011;11:125. PubMed PMC

Hoffmann C., Gaietta G., Lohse M.J. Fluorescent labeling of tetracysteine-tagged proteins in intact cells. Nat. Protoc. 2010;5:1666–1677. PubMed PMC

Roberti M.J., Bertoncini C.W., Jovin T.M. Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged α-synuclein. Nat. Methods. 2007;4:345–351. PubMed

Yap T.L., Pfefferkorn C.M., Lee J.C. Residue-specific fluorescent probes of α-synuclein: detection of early events at the N- and C-termini during fibril assembly. Biochemistry. 2011;50:1963–1965. PubMed PMC

Mučibabić M., Apetri M.M., Aartsma T.J. The effect of fluorescent labeling on α-synuclein fibril morphology. Biochim. Biophys. Acta. 2016;1864:1419–1427. PubMed

Roberti M.J., Fölling J., Jares-Erijman E.A. Imaging nanometer-sized α-synuclein aggregates by superresolution fluorescence localization microscopy. Biophys. J. 2012;102:1598–1607. PubMed PMC

Yushchenko D.A., Fauerbach J.A., Jovin T.M. Fluorescent ratiometric MFC probe sensitive to early stages of α-synuclein aggregation. J. Am. Chem. Soc. 2010;132:7860–7861. PubMed

Roberti M.J., Jovin T.M., Jares-Erijman E. Confocal fluorescence anisotropy and FRAP imaging of α-synuclein amyloid aggregates in living cells. PLoS One. 2011;6:e23338. PubMed PMC

Izawa Y., Tateno H., Kawata Y. Role of C-terminal negative charges and tyrosine residues in fibril formation of α-synuclein. Brain Behav. 2012;2:595–605. PubMed PMC

Murray I.V., Giasson B.I., Lee V.M. Role of α-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry. 2003;42:8530–8540. PubMed

Levitan K., Chereau D., Millhauser G.L. Conserved C-terminal charge exerts a profound influence on the aggregation rate of α-synuclein. J. Mol. Biol. 2011;411:329–333. PubMed PMC

Hoyer W., Cherny D., Jovin T.M. Impact of the acidic C-terminal region comprising amino acids 109–140 on α-synuclein aggregation in vitro. Biochemistry. 2004;43:16233–16242. PubMed

Antony T., Hoyer W., Subramaniam V. Cellular polyamines promote the aggregation of α-synuclein. J. Biol. Chem. 2003;278:3235–3240. PubMed

Biancalana M., Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta. 2010;1804:1405–1412. PubMed PMC

Iyer A., Roeters S.J., Subramaniam V. The impact of N-terminal acetylation of α-synuclein on phospholipid membrane binding and fibril structure. J. Biol. Chem. 2016;291:21110–21122. PubMed PMC

Hoyer W., Antony T., Subramaniam V. Dependence of α-synuclein aggregate morphology on solution conditions. J. Mol. Biol. 2002;322:383–393. PubMed

Sidhu A., Segers-Nolten I., Subramaniam V. Solution conditions define morphological homogeneity of α-synuclein fibrils. Biochim. Biophys. Acta. 2014;1844:2127–2134. PubMed

Hoyer W., Cherny D., Jovin T.M. Rapid self-assembly of α-synuclein observed by in situ atomic force microscopy. J. Mol. Biol. 2004;340:127–139. PubMed

Zhang F., Lin X.J., Hu H.Y. Assembly of α-synuclein fibrils in nanoscale studied by peptide truncation and AFM. Biochem. Biophys. Res. Commun. 2008;368:388–394. PubMed

Dearborn A.D., Wall J.S., Steven A.C. α-Synuclein amyloid fibrils with two entwined, asymmetrically associated protofibrils. J. Biol. Chem. 2016;291:2310–2318. PubMed PMC

van Raaij M.E., Segers-Nolten I.M., Subramaniam V. Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from α-synuclein mutants. Biophys. J. 2006;91:L96–L98. PubMed PMC

Segers-Nolten I., van der Werf K., Subramaniam V. Quantitative characterization of protein nanostructures using atomic force microscopy. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007;2007:6609–6612. PubMed

Sidhu A., Nolten I.S., Subramaniam V. Distinct mechanisms determine α-synuclein fibril morphology during growth and maturation. ACS Chem. Neurosci. 2016;8:538–547. PubMed

Esler W.P., Stimson E.R., Maggio J.E. Alzheimer’s disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry. 2000;39:6288–6295. PubMed

Collins S.R., Douglass A., Weissman J.S. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol. 2004;2:e321. PubMed PMC

Jain S., Udgaonkar J.B. Evidence for stepwise formation of amyloid fibrils by the mouse prion protein. J. Mol. Biol. 2008;382:1228–1241. PubMed

Gobbi M., Colombo L., Salmons M. Gerstmann-Sträussler-Scheinker disease amyloid protein polymerizes according to the “dock-and-lock” model. J. Biol. Chem. 2006;281:843–849. PubMed